Key Financial Figures (₹ in Millions)

Income Statement Highlights:

  • Revenue from Operations: ₹18,350 million (Q1 FY27) vs ₹11,008 million (Q1 FY26)
  • Other Income: ₹889 million (Q1 FY27) vs ₹466 million (Q1 FY26)
  • Total Income: ₹19,239 million (Q1 FY27) vs ₹11,474 million (Q1 FY26)
  • Profit Before Tax: ₹4,021 million (Q1 FY27) vs ₹2,064 million (Q1 FY26)
  • Tax Expense: ₹805 million (Q1 FY27) vs ₹443 million (Q1 FY26)
  • Profit for the Period: ₹3,216 million (Q1 FY27) vs ₹1,621 million (Q1 FY26)
  • Total Comprehensive Income: ₹3,211 million (Q1 FY27) vs ₹1,539 million (Q1 FY26)

Expense Breakdown (Q1 FY27):

  • Cost of Materials Consumed: ₹10,427 million
  • Purchases of Stock-in-Trade: ₹683 million
  • Changes in Inventories: (₹743) million
  • Employee Benefits Expense: ₹1,128 million
  • Finance Costs: ₹43 million
  • Depreciation and Amortisation: ₹501 million
  • Other Expenses: ₹3,179 million
  • Total Expenses: ₹15,218 million

Other Comprehensive Income:

  • Remeasurement loss of Defined Benefit Plan: (₹7) million
  • Tax on remeasurement: ₹2 million
  • Total Other Comprehensive Loss: (₹5) million

Capital Structure:

  • Paid up Equity Share Capital: ₹449 million (Face Value ₹10)
  • Reserves: Not quantified in disclosure
  • Earnings per share (basic and diluted): ₹71.56 (not annualized)

Comparative Performance

  • Q1 FY27 vs Q1 FY26: Revenue increased 66.7%, Net Profit increased 98.4%
  • Previous quarter (Q4 FY26): Revenue ₹19,146 million, Net Profit ₹2,787 million
  • Full Year FY26 (Audited): Revenue ₹19,333 million, Net Profit ₹2,787 million

Significant Transaction

Other Income Details:

  • Gain on Divestment of Marketing Rights for Formulated Products: ₹639 million (Q1 FY27)
  • This represents the majority of the ₹889 million Other Income for the quarter

Governance and Approval Process

  • Board Meeting: Held on August 5, 2026, from 4:30 PM to 5:00 PM IST
  • Review Process: Results reviewed by Audit Committee and approved by Board of Directors
  • Auditor Review: Subjected to limited review by Statutory Auditors, Deloitte Haskins & Sells LLP (ICAI Firm Registration No. 117366W/W-100018)
  • Auditor Conclusion: No material misstatements found in the financial results

Business Context

  • Segment Information: Single reportable business segment - "Agri Care"
  • Seasonality: Business is seasonal in nature, quarterly figures not necessarily representative of full year performance
  • Corporate Structure: No subsidiaries, joint ventures, or associate companies, hence no consolidated financial results required